Epidermal growth factor receptor (EGFR) inhibitor associated skin eruption.
EGFR Inhibitors are used to treat Non-Small-Cell Lung Cancer (NSCLC) and colorectal cancer (CRC). A common side effect of EGFR Inhibitors is a follicular/pustular skin eruption. We report a case of gefitinib (Iressa) associated skin eruption. The treatment regimen consisted of triamcinolone 0.1% cream twice daily, clindamycin 1% lotion twice daily and sodium sulfacetamide lotion twice daily. The clinical presentation, etiology, and management options of EGFR Inhibitor associated skin eruptions are discussed.
Seiverling
Elizabeth V
EV
Penn State College of Medicine, Hershey, PA 17033, USA.
Fernanadez
Emmy M
EM
Adams
David
D